Status:
COMPLETED
Neurotherapy to Promote Emotion Recognition in Autism
Lead Sponsor:
Virginia Polytechnic Institute and State University
Conditions:
Autism Spectrum Disorder
Eligibility:
MALE
16-29 years
Phase:
NA
Brief Summary
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder, more prevalent than previously thought and heterogeneous in expression, though uniformly characterized by severe social disability. The...
Detailed Description
Individuals with autism spectrum disorder (ASD) are known to have difficulty in the recognition of facial emotion. Such deficits in facial emotion recognition (FER) are thought to cause or exacerbate ...
Eligibility Criteria
Inclusion
- diagnosis of ASD
Exclusion
- No severe psychopathology which warrants other immediate treatment
Key Trial Info
Start Date :
September 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT03376373
Start Date
September 1 2016
End Date
December 31 2019
Last Update
September 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Child Study Center
Blacksburg, Virginia, United States